Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Ladanyi

Showing results (51-60 of 569) with videos related to

Pageof 57
Sort By:
Lung Cancer (Amsterdam, Netherlands)|December 7, 2010
Detection of EGFR mutations in plasma DNA from lung cancer patients by mass spectrometry genotyping is predictive of tumor EGFR status and response to EGFR inhibitorsMarie Brevet, Melissa L Johnson, Christopher G Azzoli, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 20, 2012
ALK-rearranged lung cancer: adenosquamous lung cancer masquerading as pure squamous carcinomaJamie E Chaft, Natasha Rekhtman, Marc Ladanyi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2003
Homozygous deletion of CDKN2A and codeletion of the methylthioadenosine phosphorylase gene in the majority of pleural mesotheliomasPeter B Illei, Valerie W Rusch, Maureen F Zakowski, et al.
Cancer|February 18, 2003
The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusionsPeter B Illei, Marc Ladanyi, Valerie W Rusch, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 14, 2011
Incorporation of crizotinib into the NCCN guidelinesGregory J Riely, Jamie E Chaft, Marc Ladanyi, et al.
Sarcoma|August 5, 2021
Prospects for Epigenetic Targeted Therapies of Bone and Soft-Tissue SarcomasJun Wang, Arielle Elkrief, Wei Guo, et al.
American Journal of Clinical Pathology|May 21, 2004
HER-2 testing in breast cancer using immunohistochemical analysis and fluorescence in situ hybridization: a single-institution experience of 2,279 cases and comparison of dual-color and single-color scoringPriti Lal, Paulo A Salazar, Clifford A Hudis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2004
Sp1-mediated transcriptional control of fibroblast growth factor receptor 4 in sarcomas of skeletal muscle lineageShun Jiang Yu, Lei Zheng, Marc Ladanyi, et al.
The American Journal of Surgical Pathology|August 2, 2007
Glioneuronal tumor with neuropil-like islands (GTNI): a report of 8 cases with chromosome 1p/19q deletion analysisVioletta Barbashina, Paulo Salazar, Marc Ladanyi, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 15, 2021
Molecular landscape of vulvovaginal squamous cell carcinoma: new insights into molecular mechanisms of HPV-associated and HPV-independent squamous cell carcinomaAbeer M Salama, Amir Momeni-Boroujeni, Chad Vanderbilt, et al.
Pageof 57

Showing results (51-60 of 569) with videos related to

Sort By:
Pageof 57
Lung Cancer (Amsterdam, Netherlands)|December 7, 2010
Detection of EGFR mutations in plasma DNA from lung cancer patients by mass spectrometry genotyping is predictive of tumor EGFR status and response to EGFR inhibitorsMarie Brevet, Melissa L Johnson, Christopher G Azzoli, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 20, 2012
ALK-rearranged lung cancer: adenosquamous lung cancer masquerading as pure squamous carcinomaJamie E Chaft, Natasha Rekhtman, Marc Ladanyi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2003
Homozygous deletion of CDKN2A and codeletion of the methylthioadenosine phosphorylase gene in the majority of pleural mesotheliomasPeter B Illei, Valerie W Rusch, Maureen F Zakowski, et al.
Cancer|February 18, 2003
The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusionsPeter B Illei, Marc Ladanyi, Valerie W Rusch, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 14, 2011
Incorporation of crizotinib into the NCCN guidelinesGregory J Riely, Jamie E Chaft, Marc Ladanyi, et al.
Sarcoma|August 5, 2021
Prospects for Epigenetic Targeted Therapies of Bone and Soft-Tissue SarcomasJun Wang, Arielle Elkrief, Wei Guo, et al.
American Journal of Clinical Pathology|May 21, 2004
HER-2 testing in breast cancer using immunohistochemical analysis and fluorescence in situ hybridization: a single-institution experience of 2,279 cases and comparison of dual-color and single-color scoringPriti Lal, Paulo A Salazar, Clifford A Hudis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2004
Sp1-mediated transcriptional control of fibroblast growth factor receptor 4 in sarcomas of skeletal muscle lineageShun Jiang Yu, Lei Zheng, Marc Ladanyi, et al.
The American Journal of Surgical Pathology|August 2, 2007
Glioneuronal tumor with neuropil-like islands (GTNI): a report of 8 cases with chromosome 1p/19q deletion analysisVioletta Barbashina, Paulo Salazar, Marc Ladanyi, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 15, 2021
Molecular landscape of vulvovaginal squamous cell carcinoma: new insights into molecular mechanisms of HPV-associated and HPV-independent squamous cell carcinomaAbeer M Salama, Amir Momeni-Boroujeni, Chad Vanderbilt, et al.
Pageof 57